- US12083169utility2024Alkaline Phosphatase Polypeptides and Methods of Use Thereof0 cites
- US12076376utility2024Methods for Treating Lysosomal Acid Lipase Deficiency in Patients0 cites
- US12025621utility2024Atypical Hemolytic Uremic Syndrome (AHUS) Biomarker Proteins0 cites
- US12018070utility2024Methods of Shifting an Isoelectric Profile of a Protein Product and Uses Thereof0 cites
- US12012424utility2024Process for Preparation of Bis-choline Tetrathiomolybdate0 cites
- US12012448utility2024High Concentration Anti-c5 Antibody Formulations0 cites
- US12005144utility2024Lyophilized Formulations for Factor XA Antidote0 cites
- US11965884utility2024Method of Quantitating Unbound C5 in a Sample0 cites
- US11919925utility2024Virus Filtration0 cites
- US11913039utility2024Method for Producing Recombinant Alkaline Phosphatase0 cites
- US11913951utility2024High Throughput Method for Measuring the Protease Activity of Complement C3 Convertase0 cites
- US11845966utility2023Preparation of Factor Xa Derivatives0 cites
- US11839646utility2023Antidotes for Factor Xa Inhibitors and Methods of Using the Same0 cites
- US11828683utility2023Method of Quantitating Unbound C5a in a Sample0 cites
- US11807678utility2023Methods and Compositions for Treating Complement-associated Disorders0 cites
- US11802154utility2023Humanized Anti-cd200 Antibodies and Uses Thereof0 cites
- US11761963utility2023Biomarker Signature for Predicting Tumor Response to Anti-cd200 Therapy0 cites
- US11739051utility2023Crystalline Particles of Bis-choline Tetrathiomolybdate0 cites
- US11713309utility2023Solid Forms of Cerdulatinib0 cites
- US11661414utility2023Solid Forms of Cerdulatinib0 cites